CRP and cystic fibrosis: In conclusion, stable adult patients with CF with elevated baseline hs-CRP levels (≥ 5.2 mg/L) show not only lower baseline FEV1% predicted, but worse baseline clinical disease activity and QOL scores, and increased frequency of prior-year and 1-year post-baseline PExs.